Predict your next investment

INTERNET | Internet Software & Services / Healthcare
artemetrx.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Artemetrx

Artemetrx offers a data aggregation engine that combines behavioral, medical, dental, vision, lab, and prescription drug data to provide a view of health-related utilization and expenditures. This Clinical Business Intelligence Engine transforms the standard health data into actionable information that is accessible through a web-based decision support tool. In addition, Artemetrx offers a suite of clinical intervention programs that leverage the integrated data to improve care and control costs. These programs range from pharmacy-centric programs to population health programs.In March 2012, Artemetrx was acquired by Pharmaceutical Strategies Group. The valuation of Artemetrx was undisclosed. Other terms of the deal were not released.

Artemetrx Headquarter Location

515 Maryland Way Suite 216

Brentwood, Tennessee, 37027,

United States

615-377-0730

Latest Artemetrx News

Modernized Integrated Data Technology Platform, Artemetrx, Now Available to Proactively Manage Drug Costs and Clinical Outcomes

Apr 14, 2021

Innovative health tech transforms integrated pharmacy and medical data into actionable intelligence Download Loading media player... No more waiting for custom reports. No more pulling data from multiple sources. It’s there, at your fingertips, ready for you to take action. Recognize anomalies and opportunities before they become a million-dollar problem. Discover how Artemetrx transforms billions of claims records into actionable drug management insights for over 22 million integrated lives. No more waiting for custom reports. No more pulling data from multiple sources. It’s there, at your fingertips, ready for you to take action. Recognize anomalies and opportunities before they become a million-dollar problem. Discover how Artemetrx transforms billions of claims records into actionable drug management insights for over 22 million integrated lives. April 14, 2021 08:58 AM Eastern Daylight Time DALLAS--( BUSINESS WIRE )--Modernized health tech platform, Artemetrx, is now available for the unprecedented transformation of integrated data into meaningful strategies and proactive drug cost management for employers and managed care organizations (MCO). Artemetrx is a proprietary platform developed by Pharmaceutical Strategies Group (PSG), an EPIC company. It has been revolutionized to deliver unparalleled intelligence and line-of-sight into serious challenges perpetuating out-of-control drug costs and compromised patient outcomes. “We’re rolling out this groundbreaking technological advancement, so plans immediately and continuously understand their most significant drug management opportunities and effortlessly manage against the overwhelming current of change in the pharmacy landscape,” said Michael Lonergan, RPh, President of PSG. “By leveraging the value of integrated data, PSG identifies $4.8 billion annually in actionable drug cost savings.” Plans experienced an 18 percent increase in members utilizing at least one specialty drug (2017 to 2019), according to PSG’s 2020 State of Specialty Spend and Trend Report. The need to stay ahead of the curve in managing drug costs and care has never been so crucial. Artemetrx empowers health plans and employers to do more and do it faster, with innovative features like: Total cost of care analysis to support smart clinical strategies and stronger patient outcomes Clinical rules engine powered by over 1,000 unique parameters to identify emerging fraud schemes and outlier prescribers/pharmacies before they become a million-dollar problem Integrated pharmacy and medical data for greater transparency and significant insights into medical drug management “Some of the most sophisticated health plans in the country are already using the completely modernized Artemetrx platform,” said Libby Johnson, Senior Vice President of Client Success, Clinical, and Analytics. “The MCO space is more competitive than ever. This health tech platform is setting plans apart and moving the needle for them with integrated insights.” Discover how Artemetrx transforms billions of claims records into actionable drug management insights for over 22 million integrated lives. About PSG Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG’s innovative drug management solutions, including the proprietary data and analytics platform, Artemetrx, deliver actionable insights with exceptional financial and clinical value. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year. Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Artemetrx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Artemetrx is included in 1 Expert Collection, including Value-Based Care & Population Health.

V

Value-Based Care & Population Health

644 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.